HIV PrEP - Present and Future with Long-Acting Injectables
Objectives:
1. Discuss existing CDC PrEP therapy guidelines and treatment benefits and challenges with current management options.
2.Identify long-acting PrEP therapies currently in the development pipeline and their potential role in PrEP management.
3. Explain at least two differences between existing and new PrEP management options.
4.Describe potential access to care issues that might arise in individuals at high risk of contracting HIV.
5.Discuss health disparity issues for patients living with HIV and at-risk populations.
Faculty
Tam Phan, PharmD, AAHIVP
Pronouns: He/Him/His
Assistant Professor of Clinical Pharmacy
Titus Family Department of Clinical Pharmacy
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
University of Southern California
Los Angeles, CA 90089
Clinical Pharmcy - Program Coordinator
Jeffrey Goodman Special Care Clinic
Los Angeles LGBT Center
Los Angeles, CA 90028
Dell Scholars Alumni Advisory Board Chair
HSC Office (SRH 305) Phone: 323-442-6301
Email: tamphan@usc.edu
